Womens Gentle Laxative
- Product NDC
- 21130-555
- 11-digit product format
- 211300555
- Labeler code
- 21130
- Product ID
- 21130-555_2dede456-ed44-095a-e063-6294a90aff1e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bisacodyl
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- BETTER LIVING BRANDS LLC.
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-07-10
- Substance
- BISACODYL
- Active strength
- 5 mg/1
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 21130-555 | D | Discontinued by firm | 2026-10-16 | ||
| excluded package | package | 21130-555 | 21130-555-01 | D | Discontinued by firm | 2026-10-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 21130-555-01 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 21130-555-01 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 21130-555-01 | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 21130-555-01 | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 21130-555-01 | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 21130-555-01 | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 21130-555-30 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 21130-555-01 | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 21130-555-30 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 21130-555-01 | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 21130-555-30 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 21130-555-01 | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 21130-555-01 | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 21130-555-01 | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 21130-555-01 | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Womens Gentle Laxative
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BISACODYL | 5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 10X0709Y6I | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 308753 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f2c4ed1a-5aa4-1915-e053-2a95a90a59b6 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 21130-555-30 | 2025-02-12 | C162847 | 48780-1 | 2cef2736-9f9f-d83d-e063-dadaa90ab31f | 151R_Albertsons_21130-555_Bisacodyl USP 5 mg-stimulant laxative |
| 21130-555-30 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-9f9f-d83d-e063-dadaa90ab31f | 151R_Albertsons_21130-555_Bisacodyl USP 5 mg-stimulant laxative |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21130-555-30 | Womens Gentle Laxative | 15 in 1 BLISTER PACK | TABLET | 15 | 3 | |
| 21130-555-30 | Womens Gentle Laxative | 2 in 1 CARTON | TABLET | 2 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bisacodyl | BISACODYL SUPPOSITORIES | Oncor Pharmaceuticals | 6f0aefc9-cd5f-4bdd-89c2-b6a80558987c | 2025-01-24 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | NuCare Pharmaceuticals, Inc. | 2c65319f-6cf5-aa90-e063-6394a90ad662 | 2025-01-23 | Warnings | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Cardinal Health (Leader) 70000 | cde87f95-73c0-46f5-9349-37e04096048c | 2025-01-22 | Warnings | M007 |
| Senna-Tabs | SENNA 8.6MG | Ulai Health LLC | 485129a0-8340-4f61-be51-5abff5032b8d | 2025-01-20 | Warnings | M007 |
| Fiber Laxative | CALCIUM POLYCARBOPHIL | Topco Associates, LLC | 0609468d-ee66-49af-be40-e51965b88f6f | 2025-01-20 | Warnings | M007 |
| Soluble Fiber | METHYLCELLULOSE | United Natural Foods, Inc. dba UNFI | 6decd5ef-e8e1-44ae-8465-6266cf18e81e | 2025-01-20 | Warnings | M007 |
| Perdiem | SENNOSIDES, STIMULANT LAXATIVE | Haleon US Holdings LLC | 6b256c8f-3953-4c69-9a16-ffa0511bdbcd | 2025-01-16 | Warnings | M007 |
| Senna Syrup | SENNOSIDES | Everpharm LLC | 0ea9f2b5-4533-4b71-b019-10ecb3c06459 | 2025-01-16 | Warnings | M007 |
| Anecream 5 | LIDOCAINE 5% | Focus Health Group | 1810edc3-093e-402f-bcb0-9c731da283a7 | 2025-01-15 | Warnings | M007 |
| Senna | SENNOSIDES | Reliable 1 Laboratories LLC | ae46a611-20f2-74c8-e053-2995a90a32ce | 2025-01-15 | Warnings | M007 |
| Sennosides and Docusate Sodium | SENNOSIDES, DOCUSATE SODIUM | Reliable-1 Laboratories LLC | a97a1829-f62f-2014-e053-2a95a90a8cc5 | 2025-01-15 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | NCS HealthCare of KY, LLC dba Vangard Labs | 4d678da0-9ada-4d00-9db9-33b45c776107 | 2025-01-15 | Warnings | M007 |
| Goodsense Fiber laxative 147 | CALCIUM POLYCARBOPHIL | GoodSense | 17f5570b-be85-9dce-e063-6294a90abeaf | 2025-01-14 | Warnings | M007 |
| Sunmark Mineral Oil Laxative | MINERAL OIL | Strategic Sourcing Services | c54f7df2-3845-425f-b13e-3dc000123f3c | 2025-01-14 | Warnings | M007 |
| Senna-S | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Ulai Health LLC | c0e27b02-8ef2-4239-8f8c-790f7d978dc0 | 2025-01-12 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | Major Pharmaceuticals | 1541ff5b-11f8-444b-a2a0-8e3086ae650a | 2025-01-10 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | AvPAK | f31a4349-7826-45c0-9388-6b938d167b7a | 2025-01-09 | Warnings | M007 |
| Docusate sodium | DOCUSATE SODIUM | APNAR PHARMA LP | 05b0732b-012f-78ee-e063-6294a90a839a | 2025-01-09 | Warnings | M007 |
| Foster and Thrive Ready to Use Saline Laxative | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | McKesson | e5fdfcfd-5340-4929-9f68-2696110cca8e | 2025-01-07 | Warnings | M007 |
| Calcium Polycarbophil | CALCIUM POLYCARBOPHIL | SHANDONG XINHUA PHARMACEUTICAL CO., LTD. | ee06868b-f741-8da2-e053-2a95a90a9772 | 2025-01-02 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308753 | bisacodyl 5 MG Delayed Release Oral Tablet | PSN | f2c4ed1a-5aa4-1915-e053-2a95a90a59b6 | 3 |
| 308753 | bisacodyl 5 MG Delayed Release Oral Tablet | SCD | f2c4ed1a-5aa4-1915-e053-2a95a90a59b6 | 3 |
| 308753 | bisacodyl 5 MG Enteric Coated Oral Tablet | SY | f2c4ed1a-5aa4-1915-e053-2a95a90a59b6 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 21130-555-30 | 21130055530 | 2 BLISTER PACK in 1 CARTON (21130-555-30) / 15 TABLET in 1 BLISTER PACK | 2 blister pack | 2023-07-10 | No | No | Current |